Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of bioactive molecules with potential applications in treating neurological disorders such as Parkinson’s disease and depression. The fluorinated moiety enhances metabolic stability and blood-brain barrier penetration, making it valuable in medicinal chemistry for optimizing drug candidates. It is also employed in the preparation of enzyme inhibitors and receptor modulators where precise stereochemistry and electronic effects are critical for activity.